Pathologic response to neoadjuvant therapy of high risk prostate cancer
Background. The role of pathological response, which develops as a result of systemic therapy for localized and locally advanced high risk prostate cancer, is not still fully understood. There are no clear indications for neoadjuvant therapy and no data on the relationship between neoadjuvant therap...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2020-11-01
|
Series: | Onkourologiâ |
Subjects: | |
Online Access: | https://oncourology.abvpress.ru/oncur/article/view/1011 |